Emilio Lence

Mycobacterium tuberculosis Shikimate Kinase Inhibitors: Design and Simulation Studies of the Catalytic Turnover

Beatriz Blanco, Verónica Prado, Emilio Lence et al. · Journal of the American Chemical Society · 2013 · 63 citations · Full text

Crystal Structure, Protein Assembly, Biomolecular Structure Prediction +21

Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection

Jorge Arca-Suárez, Juan Carlos Vázquez-Ucha, Pablo A. Fraile-Ribot et al. · Journal of Antimicrobial Chemotherapy · 2020 · 39 citations · Full text

Challenging Antimicrobial Susceptibility and Evolution of Resistance (OXA-681) during Treatment of a Long-Term Nosocomial Infection Caused by a Pseudomonas aeruginosa ST175 Clone

Jorge Arca-Suárez, Pablo A. Fraile-Ribot, Juan Carlos Vázquez-Ucha et al. · Antimicrobial Agents and Chemotherapy · 2019 · 27 citations · Full text

Bicyclic Boronate β‐Lactamase Inhibitors: The Present Hope against Deadly Bacterial Pathogens

Emilio Lence, Concepción González‐Bello · Advanced Therapeutics · 2021 · 25 citations · Full text

Antimicrobial Chemotherapy, Present Hope, Bacterial Pathogens +20

6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of <i>Pseudomonas aeruginosa</i> to β-Lactam Antibiotics

Juan Carlos Vázquez-Ucha, Diana Rodríguez, Cristina Lasarte-Monterrubio et al. · Journal of Medicinal Chemistry · 2021 · 24 citations